AI Article Synopsis

  • The study aimed to assess the effectiveness of CT enhancement in identifying lymph node metastasis in papillary thyroid carcinoma by analyzing Hounsfield units (HU) from both enhanced and plain scans of lymph nodes and comparing these to a muscle reference.
  • Retrospective analysis was conducted on CT scans from 114 lymph nodes that tested positive for metastasis and 143 that were negative, with various HU metrics calculated to determine the diagnostic accuracy of different enhancement measurements.
  • Results showed significant differences in HU values between metastasis-positive and negative lymph nodes, with high diagnostic efficacy for CT measurements, and there was strong agreement among different observers in interpreting the scans.

Article Abstract

Objectives: To evaluate the value of computed tomography (CT) enhancement degree in diagnosing lymph node (LN) metastasis in papillary thyroid carcinoma (PTC) by determining the ratio and difference between the Hounsfield units (HU) of CT enhancement and plain scan of the LNs, as well as between the HU of CT-enhanced LNs and the sternocleidomastoid muscle.

Methods: The plain and enhanced CT findings of 114 metastasis-positive LNs in 89 cases and 143 metastasis-negative LNs in 114 cases of PTC were analyzed retrospectively. Plain HU of LNs (PN), enhanced HU of LNs (EN), and enhanced HU of the sternocleidomastoid muscle (EM) were measured. The EN, difference between EN and PN (EN-PN), ratio of EN to PN (EN/PN), difference between EN and EM (EN-EM), and ratio of EN to EM (EN/EM) in metastasis-positive and metastasis-negative LN groups were calculated, the corresponding diagnostic efficacy for differentiating metastasis-positive from metastasis-negative LNs in PTC were sought using the receiver-operating curve. The interobserver agreement between readers was assessed using the interobserver correlation coefficient (ICC).

Results: The EN of 114 metastasis-positive LNs and 143 metastasis-negative LNs was 113.39 ± 24.13 and 77.65 ± 15.93, EN-PN was 65.84 ± 21.72 HU and 34.07 ± 13.63 HU, EN/PN was 2.36 (1.98, 2.75) and 1.76 (1.54, 2.02), EN-EM was 49.42 ± 24.59 HU and 13.27 ± 15.41 HU, and EN/EM was 1.79 ± 0.40 and 1.21 ± 0.24, respectively (all < 0.001). The area under the curve, cutoff value, sensitivity, specificity, and accuracy of EN for identifying metastasis-positive and metastasis-negative LNs were 0.895, 97.3 HU, 0.746, 0.895, and 0.829, EN-PN was 0.894, 47.8 HU, 0.807, 0.874, and 0.844, EN/PN was 0.831, 1.9, 0.877, 0.650, and 0.751, EN-EM was 0.890, 26.4 HU, 0.807, 0.839, and 0.825, and EN/EM was 0.888, 1.5, 0.728, 0.902, and 0.825, respectively. The readers had an excellent interobserver agreement on these five parameters (ICC = 0.874-0.994).

Conclusion: In the preoperative evaluation of LN metastasis in PTC, EN, EN-PN, EN-EM, and EN/EM had similarly high diagnostic efficacy, with EN, EN-PN, and EN/EM having higher specificity and EN-PN and EN-EM having higher sensitivity.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073713PMC
http://dx.doi.org/10.3389/fendo.2023.1103434DOI Listing

Publication Analysis

Top Keywords

metastasis-negative lns
16
metastasis-positive metastasis-negative
12
lns
10
enhancement degree
8
lymph node
8
node metastasis
8
metastasis papillary
8
papillary thyroid
8
ratio difference
8
114 metastasis-positive
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!